Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chanisa Thonusin

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Molecular Medicine (Cambridge, Mass.)|March 11, 2022
Effectiveness of high cardiorespiratory fitness in cardiometabolic protection in prediabetic ratsChanisa Thonusin, Patcharapong Pantiya, Natticha Sumneang, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 17, 2024
Donepezil ameliorates gut barrier disruption in doxorubicin-treated ratsKanokphong Suparan, Sirawit Sriwichaiin, Chanisa Thonusin, et al.
Scientific Reports|May 20, 2022
D-galactose-induced aging aggravates obesity-induced bone dyshomeostasisNapatsorn Imerb, Chanisa Thonusin, Wasana Pratchayasakul, et al.
Toxicology and Applied Pharmacology|September 2, 2019
The comparative effects of high dose atorvastatin and proprotein convertase subtilisin/kexin type 9 inhibitor on the mitochondria of oxidative muscle fibers in obese-insulin resistant female ratsChanisa Thonusin, Nattayaporn Apaijai, Thidarat Jaiwongkam, et al.
Menopause (New York, N.Y.)|June 25, 2020
A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived ratsChanisa Thonusin, Patcharapong Pantiya, Thidarat Jaiwongkam, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 25, 2025
Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarctionNattayaporn Apaijai, Tanawat Attachaipanich, Chayodom Maneechote, et al.
Archives of Biochemistry and Biophysics|June 28, 2020
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese ratsBusarin Arunsak, Wasana Pratchayasakul, Patchareeya Amput, et al.
Life Sciences|August 11, 2022
Deferiprone has less benefits on gut microbiota and metabolites in high iron-diet induced iron overload thalassemic mice than in iron overload wild-type mice: A preclinical studySirawit Sriwichaiin, Parameth Thiennimitr, Chanisa Thonusin, et al.
Toxicology and Applied Pharmacology|October 20, 2023
Ferroptosis inhibitor improves cardiac function more effectively than inhibitors of apoptosis and necroptosis through cardiac mitochondrial protection in rats with iron-overloaded cardiomyopathySirinart Kumfu, Jirapas Sripetchwandee, Chanisa Thonusin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisTitikorn Chunchai, Hiranya Pintana, Patcharapong Pantiya, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Molecular Medicine (Cambridge, Mass.)|March 11, 2022
Effectiveness of high cardiorespiratory fitness in cardiometabolic protection in prediabetic ratsChanisa Thonusin, Patcharapong Pantiya, Natticha Sumneang, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 17, 2024
Donepezil ameliorates gut barrier disruption in doxorubicin-treated ratsKanokphong Suparan, Sirawit Sriwichaiin, Chanisa Thonusin, et al.
Scientific Reports|May 20, 2022
D-galactose-induced aging aggravates obesity-induced bone dyshomeostasisNapatsorn Imerb, Chanisa Thonusin, Wasana Pratchayasakul, et al.
Toxicology and Applied Pharmacology|September 2, 2019
The comparative effects of high dose atorvastatin and proprotein convertase subtilisin/kexin type 9 inhibitor on the mitochondria of oxidative muscle fibers in obese-insulin resistant female ratsChanisa Thonusin, Nattayaporn Apaijai, Thidarat Jaiwongkam, et al.
Menopause (New York, N.Y.)|June 25, 2020
A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived ratsChanisa Thonusin, Patcharapong Pantiya, Thidarat Jaiwongkam, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 25, 2025
Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarctionNattayaporn Apaijai, Tanawat Attachaipanich, Chayodom Maneechote, et al.
Archives of Biochemistry and Biophysics|June 28, 2020
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese ratsBusarin Arunsak, Wasana Pratchayasakul, Patchareeya Amput, et al.
Life Sciences|August 11, 2022
Deferiprone has less benefits on gut microbiota and metabolites in high iron-diet induced iron overload thalassemic mice than in iron overload wild-type mice: A preclinical studySirawit Sriwichaiin, Parameth Thiennimitr, Chanisa Thonusin, et al.
Toxicology and Applied Pharmacology|October 20, 2023
Ferroptosis inhibitor improves cardiac function more effectively than inhibitors of apoptosis and necroptosis through cardiac mitochondrial protection in rats with iron-overloaded cardiomyopathySirinart Kumfu, Jirapas Sripetchwandee, Chanisa Thonusin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisTitikorn Chunchai, Hiranya Pintana, Patcharapong Pantiya, et al.
Pageof 7